LQDA Liquidia Technologies Inc

$27.30

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 8/22/2025

About Liquidia Technologies Inc

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and markets various products for the unmet needs of patients in the United States. The company is headquartered in Morrisville, North Carolina.

Website: https://www.liquidia.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1819576
Address
P.O. BOX 110085, RESEARCH TRIANGLE PARK, NC, US
Valuation
Market Cap
$1.17B
P/E Ratio
nan
PEG Ratio
nan
Price to Book
15.14
Performance
EPS
$-1.66
Dividend Yield
—
Profit Margin
0.00%
ROE
-209.40%
Technicals
50D MA
$14.84
200D MA
$12.18
52W High
$16.81
52W Low
$8.26
Fundamentals
Shares Outstanding
85M
Target Price
$26.78
Beta
0.22

LQDA EPS Estimates vs Actual

● Estimated
● Actual

LQDA News & Sentiment

Aug 13, 2025 • Benzinga SOMEWHAT-BULLISH
Liquidia Analysts Raise Their Forecasts Following Q2 Results - Liquidia ( NASDAQ:LQDA )
Liquidia Corporation LQDA reported a loss for the second quarter on Tuesday. The company posted a second-quarter loss of 49 cents, missing the consensus of a loss of 43 cents. Sales reached $8.84 million compared to the consensus of $3.86 million.
Aug 12, 2025 • Zacks Commentary NEUTRAL
Liquidia Technologies, Inc. ( LQDA ) Reports Q2 Loss, Beats Revenue Estimates
Liquidia Technologies (LQDA) delivered earnings and revenue surprises of -13.95% and +124.46%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Aug 12, 2025 • Benzinga NEUTRAL
Why Is Liquidia Stock Trading Higher On Tuesday? - Liquidia ( NASDAQ:LQDA )
Q2 loss of $0.49 vs. $0.43 estimate; sales surge to $8.84 million after Yutrepia launch. PH-ILD study shows stable tolerability; median walk distance improved by 31.5m. The next 100%+ earnings move could hit this month. See how to find it live on Wednesday →
Aug 12, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update
MORRISVILLE, N.C., Aug. 12, 2025 ( GLOBE NEWSWIRE ) -- Liquidia Corporation ( NASDAQ: LQDA ) , a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary diseases, today announced its financial results for the second quarter ended June 30, 2025.
Aug 05, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025
MORRISVILLE, N.C., Aug. 05, 2025 ( GLOBE NEWSWIRE ) -- Liquidia Corporation ( NASDAQ: LQDA ) , a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that it will report its second quarter 2025 financial results on Tuesday, ...
Jul 31, 2025 • Zacks Commentary NEUTRAL
Vericel Corporation ( VCEL ) Reports Q2 Loss, Lags Revenue Estimates
Vericel (VCEL) delivered earnings and revenue surprises of +75.00% and -1.33%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Sentiment Snapshot

Average Sentiment Score:

0.137
50 articles with scored sentiment

Overall Sentiment:

Neutral

LQDA Reported Earnings

Mar 11, 2025
Dec 31, 2024 (Pre market)
-0.06 Surprise
  • Reported EPS: $-0.45
  • Estimate: $-0.40
  • Whisper: —
  • Surprise %: -13.9%
Nov 05, 2024
Sep 30, 2024 (Pre market)
-0.02 Surprise
  • Reported EPS: $-0.39
  • Estimate: $-0.37
  • Whisper: —
  • Surprise %: -4.8%
Aug 07, 2024
Jun 30, 2024 (Pre market)
-0.03 Surprise
  • Reported EPS: $-0.37
  • Estimate: $-0.34
  • Whisper: —
  • Surprise %: -8.8%
May 13, 2024
Mar 31, 2024 (Post market)
-0.22 Surprise
  • Reported EPS: $-0.54
  • Estimate: $-0.32
  • Whisper: —
  • Surprise %: -68.8%
Mar 13, 2024
Dec 31, 2023 (Pre market)
-0.18 Surprise
  • Reported EPS: $-0.42
  • Estimate: $-0.24
  • Whisper: —
  • Surprise %: -75.0%
Nov 07, 2023
Sep 30, 2023 (Pre market)
-0.03 Surprise
  • Reported EPS: $-0.24
  • Estimate: $-0.21
  • Whisper: —
  • Surprise %: -14.3%
Aug 10, 2023
Jun 30, 2023 (Pre market)
-0.2 Surprise
  • Reported EPS: $-0.36
  • Estimate: $-0.16
  • Whisper: —
  • Surprise %: -125.0%
May 04, 2023
Mar 31, 2023 (Pre market)
-0.02 Surprise
  • Reported EPS: $-0.18
  • Estimate: $-0.16
  • Whisper: —
  • Surprise %: -12.5%
Mar 16, 2023
Dec 31, 2022 (Pre market)
0.06 Surprise
  • Reported EPS: $-0.09
  • Estimate: $-0.15
  • Whisper: —
  • Surprise %: 40.0%

Financials